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Precocene II (6,7-dimethoxy-2,2-dimethyl-2-chromene) was the main constituent isolated from Ageratum 
conyzoides L. and reportedly possessed antifungal activity. The study investigated the isolation, 
purification and toxicological effects of precocene II from A. conyzoides in Sprague Dawley rats. 
Precocene II was isolated from the petroleum ether fraction of the plant and the structure was 
determined by 1H-,13C-,DEPT-NMR and MS spectral techniques. Three groups of eight rats per group 
were used for the study. While groups B and C were respectively administered with 25 and 50 mg/kg of 
precocene II in 0.25% CMC-Na for 11 days by gastric intubation, group A was administered with 0.25% 
CMC-Na and served as the control group. After the last treatment, animals were fasted overnight and on 
the 12th day, they were injected intravenously with 0.2 ml/kg body weight of phenobarbital. Animals 
were subsequently dissected from the abdominal region; blood was collected from the pulmonary vein 
into EDTA anti-coagulated and non anti-coagulated tubes.  The liver, kidney and spleen tissues were 
extracted into separate bottles for histopathological examinations. Results from hematological study 
indicated that the white blood cell (WBC), red blood cell (RBC), plateletcrit (PCT) and mean corpuscular 
hemoglobin count (MCHC) were significantly higher across the treated groups. Biochemical result 
showed that serum glucose level was significantly reduced in the treated groups. No apparent damage 
was noticed in the liver, kidney and spleen tissues. The result therefore suggests that precocene II 
possesses hypoglycemic property and could alter some hematopoietic elements but was not toxic to 
the liver, kidney and spleen tissues.  
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INTRODUCTION 
 
Ageratum conyzoides L. belongs to the family of 
asteraceae and native to Central America, Caribbean, 
Florida (USA), Southeast Asia, South China, India, West 
African (including Nigeria), Australia and South America 
(Okunade, 2002; Kong,  2006).  A. conyzoides  has  been  
 
 
 
*Corresponding authors.  E-mail:  nhtan@mail.kib.ac.cn; 
aadebayo@covenantuniversity.com Tel: +2348036357197. Fax: 
+86 871 5223800 
widely reported to contain many bioactive compounds 
which are responsible for its diverse biological activities. 
The phytochemical compounds mostly isolated were from 
the oil extract of the plant in which precocene I and II are 
the major constituents (Okunade, 2002). Precocene I (7-
methoxy-2,2-dimethyl-2-chromene) and precocene II 
(6,7-dimethoxy-2,2-dimethyl-2-chromene) have been 
used as insect regulators by inducing symptoms of 
juvenile deficiency hormone in insects (Schrankel et al., 
1982). Metabolism of precocenes in insects and rats has 
been  previously  studied  (Hsia et al.,  1981;  Haunerland  
  
 
 
and Bowers, 1985) and parallel views have been drawn 
between the formation of carcinogenic bay region diol 
epoxides from polycyclic aromatic hydrocarbons in 
mammals and the bioactivation of precocenes by insects 
and rats (Pratt et al., 1980; Halpin et al., 1982). Various 
species of "Streptomyces," "Aspergillus," "Rhodotorula," 
"Brevilegnia," "Syncephalastrum" and "Stysanus" were 
found to transform precocene II to three major meta-
bolites identified as cis- and (+) trans-precocene II-3,4-
dihydrodiols and (+)-3-chromenol. 1802 incorporation 
studies indicated the involvement of a monooxygenase 
enzyme system in precocene II transformation by 
Streptomyces griseus (Sariaslani et al., 1987). Precocene 
II has also been reported to completely inhibit two 
species of fungi, Rhizoctonia solani and Sclerotium rolfsii 
(Iqbal et al., 2004). Precocene II was found to be a more 
potent analog and selectively destroys the corpora allata of 
insects, terminating production of the juvenile hormone. 
Precocenes are now widely used as tools in experimental 
arthropod endocrinology and have been considered 
prototypes of "fourth-generation" pesticides (Sariaslani et 
al., 1987). Toxicity studies of naturally derived precocene 
are lacking and to the best of the present knowledge, there 
has been no detailed report of hematological parameters on 
animals treated with precocene II. Thus, this research 
investigated the toxicological effects of naturally occurring 
precocene II isolated from A. conyzoides in Sprague 
Dawley (SD) rat using biochemical, hematological and 
histopathological indices of toxicity. 
 
 
MATERIALS AND METHODS 
 
Plant collection and identification 
 
The whole plant of A. conyzoides L. was obtained in April, 2008 
from Xushuangbanna, South Western China and authenticated by 
Dr. You-Kai Xu of the Xushuangbanna Tropical Botanical Garden, 
Chinese Academy of Sciences, China. A voucher specimen (KUN 
0486260) was subsequently deposited in the Herbarium of Kunming 
Institute of Botany-CAS, China. 
 
 
Plant extraction, isolation and structure elucidation 
 
The dried whole plant (7 kg) of A. conyzoides was extracted with 
95% ethanol for three times (each for one week) at room 
temperature. After concentration of the combined extracts under 
reduced pressure, the residue was dissolved in hot water and 
extracted successively with petroleum ether, ethyl acetate and n-
butanol. The petroleum ether (201 g) was fractionated by column 
chromatography (CC) (268 g silica gel; Pet. Ether /Acetone 1:6, 1:3 
and 1:1) to afford several fractions. The first fraction was purified by 
repeated CC (1. sephadex LH-20, CHCl3: MeOH 2:1 and 2. SiO2; 
Pet. Ether./CHCl3 1:2, 10:1, to afford precocene II (2.1 g). 
Precocene II was obtained as yellow oil. Its molecular weight from 
EI-MS (VG Autospec-3000, UK) was 220. From the 1H, 13C-NMR 
and DEPT spectra (Bruker AM-400 and DRX-500, Rheinstteten, 
Germany), the molecular formular, C13H16O3 was derived. 
Furthermore, the 1H and 13C-NMR data showed that this compound 
was   a   chromene   and  when  compared  with  literatures,  it  was  
identified as 6, 7-dimethoxy-2,2-dimethyl-2-chromene (precocene II) 
(Gonzalez   et  al.,  1991;   Iqbal  et al.,  2004).   (6,7-dimethoxy-2,2-  
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Figure 1. Structure of precocene II. 
 
 
 
dimethyl-2-chromene, Precocene II), pale yellow oil, C13H16O3, 1H-
NMR (500 MHz, CD3OD) H: 5.47(1H, d, J = 9.7 Hz,  H-3), 6.24(1H, 
d, J = 9.7, H-4), 6.53(1H, s, H-5), 6.41(1H, s, H-8), 1.41(6H, s, 2x 
CH3 at C-2), 3.77(6H, s, 2x –OCH3 at C-6,7). 13C-NMR (125 MHz, 
CD3OD), c: 75.9(s, C-2), 128.2(d, C-3), 121.9(d, C-4), 149.6(s, C-
4a), 109.7(d, C-5), 143.0(s, C-6), 147.2(s, C-7), 101.0(d, C-8), 
113.0(s, C-8a), 27.6(q, 2x CH3, C-9/10), 56.5(q,  –OCH3, C-13), 
55.8(q, -OCH3, C-14). EI-MS m/z (%): 220 [M]+ (30), 205 (34), 191 
(25), 177 (36),  165 (95), 95 (100), 81 (62), 69 (44) (Figure 1). 
 
 
Experimental animals 
 
Twenty-four male SD rats, specific pathogen free (SPF), aged 7 - 9 
weeks and weighing 220 – 265 g were purchased from Vital River 
Laboratories, Beijing, China and transported by air to the Animal 
House of the Institute of Toxicology, Kunming Medical University, 
Kunming, China. They were kept under standard environmental 
conditions (25 + 21°C; 12/12 h light/dark cycle). Four animals were 
housed in each cage and fed with standard diet (obtained from 
Yunnan Key Laboratory of Animal Nutrition and Feed Stuff, Yunnan 
Agriculture University, Kunming, China) and water ad libitum. The 
animals were allowed to acclimatize before beginning the 
experiment. For experimentation, the animals were fasted overnight 
and 8 animals were included in each group. All animals were 
treated in compliance with the guidelines of National Institute of 
Health (NIH) Guidelines for the Care and Use of Laboratory 
Animals (NIH publication, 1985). Also, the animal protocols of the 
Institute of Toxicology, Kunming Medical University Ethics 
Committee on Research in Animals were followed.  
 
 
Experimental design 
 
In the experimental design, sub-chronic toxicity study was carried 
out on the compound (precocene II) isolated from A. conyzoides. 
Two groups (B and C) of eight rats per group were respectively 
administered 25 and 50 mg/kg body weight doses of precocene II in 
0.25% CMC-Na for 11 days via gastric intubation. Animals in group 
A (control group) also made up of eight rats were administered with 
0.25% CMC-Na per kg body weight. On the 12th day, animals were 
injected intravenously with 0.2 ml/kg body weight of phenobarbital 
(sedative). They were subsequently dissected from the abdominal 
region; blood was collected from the pulmonary vein using the 
vacutainer collection set into EDTA anti-coagulated and non anti-
coagulated bottles.  The liver, kidney, heart, spleen, brain, lungs, 
thymus, testes, epidydimis and adrenal gland were extracted into 
separate bottles for histopathological examinations. The blood 
sample collected into EDTA bottles was used for hematological 
studies while the blood in non anti-coagulated bottles was 
centrifuged at 1,500 g for 10 min, and the sera collected into clean, 
dried tubes for biochemical analyses. 
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Figure 2. Weights of Sprague Dawley rats treated with precocene II isolated from Ageratum conyzoides. 
Values are represented as mean ± SEM of 8 replicates. Values on the same day with different letters differ 
significantly (p < 0.05).  
 
 
 
Biochemical and hematological assays 
 
Commercial test kits obtained from Biosino Bio-Technology and 
Science Inc. Beijing, China were used for all biochemical 
parameters measured. Standard methods were used to estimate 
glucose (Trinder, 1969), aspartate aminotransferase (AST) 
(Bergmeyer et al., 1986a), alanine aminotransferase (ALT) 
(Bergmeyer et al., 1986b), alkaline phosphatase (ALP) (Tietz et al., 
1983),  creatine kinase (CK) (Chemnitz et al., 1979), total protein 
(Weichselbaum, 1946), albumin (Doumas et al., 1971), total 
bilirubin (Doumas et al., 1973), urea (Krieg et al., 1986), creatinine 
(Larsen, 1971), triglycerides and cholesterol (Zoppi and Fellini, 
1976). These parameters were determined using the automated 
biochemical muti-item analyzer (TMS-1024; Tokyo Boeki Medical 
System Ltd., Japan). The whole blood was used to assay white 
blood cell (WBC), red blood cell  (RBC), hemoglobin (HGB), 
hematocrit (HCT), mean cell volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin concentration 
(MCHC), red cell distribution width (RDW), platelet count (PLT), 
mean platelet volume (MPV), percentage lymphocyte, percentage 
monocyte, percentage granulocyte, platelet distribution width 
(PDW) and plateletcrit (PCT) using the techniques described by 
Baker et al. (1998). These parameters were determined by the 
automated hematology system analyzer (ADVIA 60 Open Tube; 
Bayer Corporation Tarrytown New York, USA).  
 
 
Histopathological studies 
 
The method described by Aliyu et al. (2007) with slight modification 
was followed. After blood collection, the liver, kidney and spleen 
were carefully dissected from the abdominal region. They were 
fixed in normal saline for 72 h and sliced into a thickness of 2.1 mm. 
The tissues were dehydrated with alcohol of graded concentrations.  
They were further treated with paraffin wax and cast into blocks; 
sections of the tissues were then cut on a microtome to 5 µm. 
These were later attached to a slide and allowed to dry. The sample 
slides were subsequently stained in haematoxylin-eosin and 
examined under a light microscope; photomicrographs of the 
samples were recorded. 
 
 
Statistical analysis 
 
The differences among experimental and control groups were 
determined using Statistical Package for the Social Sciences 
(SPSS) for Window XP software programme (version 13.0). Group 
comparisons were done using the analysis of variance (ANOVA) 
test. Significant difference between control and experimental groups 
were assessed by least significant difference (LSD) and the 
student’s t-test. All data were expressed as mean + standard error 
of mean (SEM); p-values less than 0.05 were considered to be 
significant. 
 
 
RESULTS 
 
Animal weights and weight of organs  
 
No significant difference (p > 0.05) was observed in the 
weight of animals and organs of rats treated with 
precocene II as compared with the control (Figure 2 and 
Table 3).  
 
 
Hematological and biochemical assays 
 
The WBC was significantly higher (p < 0.01) in the group 
treated with 50 mg/kg body weight; similarly, the RBC 
was significantly elevated (p < 0.05) in the same group 
when   compared   with   the  control  group.  There  were  
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Table 1. Effects of precocene II on biochemical parameters of Sprague Dawley rats. 
  
Parameters 
Group A Group B (mg/kg body weight) Group C 
Control 25 50 
 Glucose (mmol/L) 7.01 ± 0.31a 6.04 ± 0.46b 5.70 ± 0.11c 
ALT (U/L) 42.87 ± 2.22 a 38.72 ± 3.38a 47.03 ± 5.18a 
AST (U/L) 98.92 ± 3.21a 103.54 ± 4.79a 105.56 ± 5.07a 
ALP (U/L) 226.97 ± 8.17a 233.53 ± 12.21a 217.96 ± 15.73a 
Total Bilirubin (µmol/L) 2.28 ± 0.22a 2.43 ± 0.10a 2.61 ± 0.07a 
Total Protein (g/L) 55.39 ± 0.90a 57.07 ± 1.02a 56.07 ± 0.07a 
Albumin (g/L) 36.34 ± 0.40a 36.86 ± 0.47a 36.38 ± 0.34a 
Albumin/Globulin 1.95 ± 0.10a 1.84 ± 0.05a 1.86 ± 0.04a 
Creatine kinase (U/L) 858.19 ± 151.70a 1079.39 ± 125.69a 656.94 ± 132.28a 
 Urea (mmol/L) 6.60 ± 0.34a 6.35 ± 0.16a 7.21 ± 0.43a 
Creatinine (µmol/L) 25.14 ± 1.31a 26.15 ± 0.75a 27.39 ± 0.78a 
Total Cholesterol (mmol/L) 1.51 ±0.09a 1.45 ± 0.07a 1.59 ± 0.08a 
Triglyceride (mmol/L) 0.46 ± 0.03a 0.50 ± 0.04a 0.36 ± 0.07a 
 
Values are represented as mean ± SEM of 8 replicates. Values on the same row followed by different superscript letters differ 
significantly (bp < 0.05; c p < 0.01 vs control). 
 
 
 
Table 2. Effects of precocene II on the hematological parameters of Sprague Dawley rats. 
 
   Parameters 
Group A Group B (mg/kg body weight) Group C 
Control 25 50 
WBC (x 1012/L) 4.88 ± 0.32a 5.54 ± 0.32a 6.25 ± 0.40c 
RBC (x 1012/L) 6.54 ± 0.16a 6.54 ± 0.09a 7.22 ±  0.33b 
HB (g/L) 139.00 ± 3.30a 144.29 ± 2.37a 150.50 ± 7.02a 
HCT (L/L) 0.33 ± 0.02a 0.33 ± 0.01a 0.36 ± 0.02a 
PLT (x 109/L) 1097.25 ± 44.99 a 1333.14 ± 98.78 a 1253.75 ± 82.31a 
PCT (x 10-2L/L) 0.75 ± 0.38a 0.98 ± 0.11b 0.97 ± 0.08b 
MCV (fL) 50.75 ± 0.86 a 50.86 ± 0.59a 50.38 ± 0.82a 
MCH (pg) 21.28 ± 0.43a 22.07 ± 0.25a 20.86 ± 0.37a 
MCHC (g/L) 419.00 ± 3.86a 434.57 ± 6.07b 415.25 ± 5.15a 
RDW (%) 15.11 ± 0.48a 15.03 ± 0.52 a 15.14 ± 0.50a 
MPV (fL) 6.78 ± 0.14 a 7.34 ± 0.29 a 7.25 ± 0.32a 
PDW (%) 7.13 ± 0.24a 7.50 ± 0.31a 7.23 ± 0.34a 
Lymphocyte (%) 90.50 ± 1.78a 91.04 ± 2.04a 88.51 ± 1.83a 
Monocyte (%) 7.76 ± 1.32a 7.76 ± 1.79a 9.46 ± 1.62a 
Granulocyte (%) 1.74 ± 0.50a 1.20 ± 0.38a 1.78 ± 0.38a 
 
Values are represented as mean ± SEM of 8 replicates. Values on the same row followed by different superscript letters 
differ significantly (bp < 0.05; c p < 0.01). WBC, White blood cell count; RBC, red blood cell count; HB, Hemoglobin; HCT, 
hematocrit; MCV, mean cell volume;  MCH, mean corpuscular hemoglobin, MCHC, mean corpuscular hemoglobin 
concentration; RDW, red cell distribution width; PLT, platelet count; MPV, mean platelet volume; PDW, platelet distribution 
width; PCT,  plateletcrit. 
 
 
 
significant increases (p < 0.05) in PCT in both treated 
groups. MCHC was also statistically higher (p < 0.05) in 
the group treated with 25 mg/kg of precocene II when 
compared with the control group (Table 2).  ALT, AST, 
ALP, total bilirubin, total protein, albumin, cholesterol, 
triglycerides, creatine kinase, urea and creatinine were 
not significantly different (p > 0.05) from the control 
group. Serum glucose concentration was significantly 
decreased in groups B (p < 0.05) and C (p < 0.01) (Table 
1).  
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Table 3. Effects of precocene II isolated from A. conyzoides on the weight of organs in Sprague Dawley rats. 
 
Organs Group A 
Group B 
(mg/kg body weight) Group C 
Control 25 50 
Thymus (x 10-2g) 36.09 ± 2.08
a 
[13.55 ± 0.76]a 
34.86 ± 1.89 a 
[13.07 ± 0.70]a 
36.18 ± 2.37 a 
[13.86 ± 0.84]a 
Adrenal gland  
(x 10-2 g) 
5.58 ± 0.34a 
[2.09 ± 0.10]a 
5.66 ± 0.32 a 
[2.12 ± 0.29]a 
5.65 ± 0.39 a 
[2.17 ± 0.15]a 
Heart (g) 0.96 ± 0.03
 a
 
[0.36 ± 0.01]a 
0.91 ± 0.03 a 
[0.34 ± 0.01]a 
0.91 ± 0.02 a 
[0.35 ± 0.01]a 
Liver (g) 7.36 ± 0.24
 a
 
[2.77 ± 0.09]a 
7.60 ± 0.23 a 
[2.85 ± 0.08]a 
7.45 ± 0.27 a 
[2.85 ± 0.07]a 
Spleen (g) 0.61 ± 0.06
 a
 
[0.22 ± 0.02]a 
0.54 ± 0.02 a 
[0.20 ± 0.01]a 
0.54 ± 0.04 a 
[0.21 ± 0.01]a 
Lungs (g) 1.11 ± 0.02
 a
 
[0.42 ± 0.02]a 
1.14 ± 0.03 a 
[0.43 ± 0.01]a 
1.15 ± 0.06 a 
[0.44 ± 0.02]a 
Kidney (g) 2.04 ± 0.11
a
 
[0.77 ± 0.05]a 
2.02 ± 0.08a 
[0.76 ± 0.03]a 
1.89 ± 0.06a 
[0.72 ± 0.02]a 
Brain (g) 1.85 ± 0.02
 a
 
[0.70 ± 0.02]a 
1.78 ± 0.02 a 
[0.67 ± 0.01]a 
1.81± 0.04 a 
[0.70 ± 0.02]a 
Testes (g) 2.87 ± 0.10
 a
 
[1.08 ± 0.05]a 
2.77 ± 0.06 a 
[1.04 ± 0.02]a 
2.67 ± 0.05 a 
[1.02 ± 0.02]a 
Epididymis (g) 0.81 ± 0.04
 a
 
[0.30 ± 0.02]a 
0.98 ± 0.13 a 
[0.37 ± 0.05]a 
0.84 ± 0.06 a 
[0.32 ± 0.03]a 
 
Values are represented as mean ± SEM of 8 replicates; values in parenthesis are % weight of organ with respect to 
the body weight of rats. Values on the same row followed by different superscript letters differ significantly (p < 0.05). 
 
 
 
Histopathological studies 
 
No significant damage was observed in rats’ liver, kidney 
and spleen tissues in both groups treated with precocene 
II isolated from A. conyzoides when compared with the 
control. 
 
 
DISCUSSION 
 
No deaths occurred during the period of treatment. No 
changes in locomotor activity or occurrences of 
piloerection or diarrhea were observed. Changes in body 
weight are a valuable indicator in evaluating the toxicity of 
a compound or extract preparation (Grance et al., 2008). 
The slight drop in weight after 4 days of treatment in all 
the treated groups could be a normal physiological and 
adaptational responses mediated by the compound, thus 
decreasing the appetite and thereby lowering caloric 
intake by the animals (Rhiouani et al., 2008). The weights 
subsequently picked up and may suggest that the 
compound do not exert adverse effects on the animals. 
From hematological studies, the sub-acute exposure of 
rats to both lower and higher doses (25 and 50 mg/kg, 
respectively) of the compound, precocene II produced 
significant changes in some hematological parameters. 
The increase in erythrocytes (RBC), mean corpuscular 
hemoglobin concentration (MCHC), leukocytes (WBC) 
and plateletcrit (PCT) may be due to overproduction of 
hematopoietic regulatory elements such as colony-
stimulating factors, erythropoietin and thrombopoietin by 
the stromal cells and macrophages in the bone marrow 
(Chang-Gue et al., 2003) thus providing the local 
environment for hematopoiesis (Udut et al., 2005; 
Rhiouani et al., 2008). From the observed significant 
increase in the values of WBC, it was clear that an 
increase in the number of WBC is a normal reaction of 
rats to foreign substances, which alter their normal 
physiological processes. The leucocytosis observed in 
the present study indicates a stimulation of the immune 
system which protects the rats against infection that 
might have been caused by chemical and also secondary 
infections, which may be contracted after the weakening 
condition of the rats. Leucocytosis, which may be directly 
proportional to the severity of the causative stress 
condition, may be attributed to an increase in leukocyte 
mobilization (Celik and Suzek, 2008). Biochemical 
markers are often used as basis for the assessment of 
toxicity of an organ. Thus, in the present study, no 
significant variations in the levels of AST, ALT, ALP, total 
protein, albumin, total bilirubin, urea and creatinine was 
observed   thus   suggesting   the    non-toxicity    of    the  
  
 
 
compound to the liver and kidney within the treatment 
durations. The result from histological sectioning was in 
agreement as there were no apparent liver and kidney 
injury observed in all the treated groups when compared 
to the control groups. This further confirmed that the 
compound may not be toxic to the liver and kidney within 
these treatment periods. Diabetes is a chronic metabolic 
disorder affecting a major population worldwide. A 
sustained reduction in hyperglycemia will decrease the 
risk of developing micro vascular diseases and reduce 
their complications (Kim et al., 2006). It has been 
established that lowering the plasma glucose level may 
be induced by the release of insulin, an endogenous 
peptide involved in the regulation of blood sugar (Cunha 
et al., 2008). Hence, the measurement of serum glucose 
level has been used as a marker for diabetes mellitus. 
Thus, a significant decreased in serum glucose level was 
observed in rats treated with precocene II thus 
suggesting that the compound possess hypoglycemic 
activity. This hypoglycemic effect could be attributed to 
the potentiation of insulin effect of plasma by increasing 
the pancreatic secretion of insulin from the existing -
cells or its release from bound insulin (Sharma et al., 
2008; Eidi et al., 2006; Kasiviswanath et al., 2005). 
Previous work has reported a reduction in serum glucose 
level by 21.3% after 4 h of treatment with the aqueous 
leaf extract of A. conyzoides (Nyunai et al., 2006). 
Precocene II could be the active phytochemical 
responsible for the hypoglycemic activity of this plant. 
In conclusion, precocene II was found to possess 
hypoglycemic activity and could alter some hematological 
elements with no toxicity to the liver, kidney and spleen 
tissues, and therefore might be used for the treatment of 
diabetes mellitus. Further investigation is needed to 
understand the structure-activity relationship and the 
exact hypoglycemic mechanisms of precocene II. 
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